ProKidney (PROK) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 28, 2026, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 27, 2026.

Voting matters and shareholder proposals

• Election of three directors: William F. Doyle, Alan M. Lotvin, M.D., and Brian J.G. Pereira, M.D., with board recommending a vote for each.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Proxyholders authorized to vote on other business that may arise at the meeting.

Board of directors and corporate governance

• Board recommends all director nominees for election at the annual meeting.